MedPath

北京四环科宝药业有限公司

Ownership
-
Established
2017-12-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Granisetron Hydrochloride Injection

Product Name
盐酸格拉司琼注射液
Approval Number
国药准字H20254034
Approval Date
Apr 30, 2025
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20253057
Approval Date
Jan 2, 2025
NMPA

Metformin Hydrochloride and Glipizide Tablets(Ⅱ)

Product Name
二甲双胍格列吡嗪片(Ⅱ)
Approval Number
国药准字H20140029
Approval Date
Nov 16, 2023
NMPA

Metformin Hydrochloride and Glipizide Tablets

Product Name
二甲双胍格列吡嗪片
Approval Number
国药准字H20140028
Approval Date
Nov 16, 2023
NMPA

Isosorbide Dinitrate for Injection

Product Name
瑞立喜
Approval Number
国药准字H20050523
Approval Date
Sep 10, 2020
NMPA

Isosorbide Dinitrate for Injection

Product Name
瑞立喜
Approval Number
国药准字H20050522
Approval Date
Sep 5, 2020
NMPA

Isosorbide Dinitrate for Injection

Product Name
瑞立喜
Approval Number
国药准字H20050521
Approval Date
Sep 1, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.